Epidemiological study of Guillain-Barré syndrome in south east England

OBJECTIVES To determine the incidence, treatment, and outcome of Guillain-Barré syndrome in south east England. METHODS Patients presenting with confirmed Guillain-Barré syndrome between 1 July 1993 and 30 June 1994 were recruited via a voluntary reporting scheme coordinated by the British Neurological Surveillance Unit, hospital activity data collected from acute admitting hospitals within the South East and South West Thames Regional Health Authorities, death certificates, and a contemporary research study of Guillain-Barré syndrome and Campylobacter jejuni infection. All patients were followed up for one year to determine outcome. RESULTS Seventy nine patients were recruited, 35 (44%) male, 44 (56%) female, including three children (two boys, one girl). The crude (95% confidence interval (95% CI)) annual incidence was 1.2 (0.9–1.4) cases/100 000 population and 1.5 (1.3–1.8)/100 000 when adjusted for undetected cases. Twenty (25%) patients required ventilation for an average (SD) of 42 (64) days. Thirty six (46%) patients received intravenous human immunoglobulin, five (6%) received plasma exchange, 11 (14%) both treatments, three (4%) steroids, and 25 (32%) no immunomodulatory treatment. One year later, six patients (8%) had died, all of whom were older than 60, three (4%) remained bedbound or ventilator dependent, seven (9%) were unable to walk unaided, 14 (17%) were unable to run, and 49 (62%) had made a complete or almost complete recovery. Increasing age was significantly associated with a poorer outcome at one year. CONCLUSIONS Despite the frequent use of modern immunomodulatory treatments Guillain-Barré syndrome still carries considerable morbidity and mortality.

[1]  Orman,et al.  JEJUNI INFECTION AND GUILLAIN – BARRÉ SYNDROME , 2000 .

[2]  W. Hacke,et al.  Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome , 1997 .

[3]  Plasma-ExchangeSandoglobulinGuillain-Barré Syndrome Trial Group Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome , 1997, The Lancet.

[4]  R. Hughes,et al.  Campylobacter jejuni infection and Guillain-Barré syndrome. , 1995, The New England journal of medicine.

[5]  S. Fredrikson,et al.  Guillain‐Barré syndrome in South‐West Stockholm, 1973–1991, 1. Quality of registered hospital diagnoses and incidence , 1995 .

[6]  Joana A. Rosário,et al.  Childhood Guillain‐Barré syndrome in Paraguay, 1990 to 1991 , 1994, Annals of neurology.

[7]  M. Mclean,et al.  Incidence of Guillain‐Barre Syndrome in Ontario and Quebec, 1983–1989, Using Hospital Service Databases , 1994, Epidemiology.

[8]  J. Berciano,et al.  Guillain‐Barré syndrome in Cantabria, Spain. An epidemiological and clinical study , 1994, Acta neurologica Scandinavica.

[9]  P. Schmitz,et al.  A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. , 1992, The New England journal of medicine.

[10]  G. Birkhead,et al.  The use of hospital discharge data for public health surveillance of guillain‐barré syndrome , 1991, Annals of neurology.

[11]  M. Färkkilä,et al.  Survey of Guillain-Barré syndrome in southern Finland. , 1991, Neuroepidemiology.

[12]  J. G. Evans,et al.  Age-specific incidence of Guillain-Barré syndrome in Oxfordshire. , 1990, The Quarterly journal of medicine.

[13]  M. Alter The epidemiology of Guillain‐Barré syndrome , 1990, Annals of neurology.

[14]  D. Cornblath,et al.  Assessment of current diagnostic criteria for Guillain‐Barré syndrome , 1990, Annals of neurology.

[15]  M. Salmon,et al.  Lymphopenia in Rheumatoid Arthritis , 1989, Journal of the Royal Society of Medicine.

[16]  R. Hughes,et al.  A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[17]  E. Beghi,et al.  Guillain-Barré syndrome. Clinicoepidemiologic features and effect of influenza vaccine. , 1985, Archives of neurology.

[18]  Plasmapheresis and acute Guillain‐Barre syndrome , 1985, Neurology.

[19]  S. W. Ferguson,et al.  Guillain‐Barré syndrome in Larimer County, Colorado , 1985, Neurology.

[20]  S. W. Ferguson,et al.  Guillain-Barré syndrome in Larimer County, Colorado: a high-incidence area. , 1985, Neurology.

[21]  R R Regal,et al.  Goodness-of-fit based confidence intervals for estimates of the size of a closed population. , 1984, Statistics in medicine.

[22]  K. A. McCarter Plasma Exchange in Guillain-Barré Syndrome , 1982, Nursing times.

[23]  J. Nelder,et al.  The GLIM System Release 3. , 1979 .

[24]  Stephen E. Fienberg,et al.  Discrete Multivariate Analysis: Theory and Practice , 1976 .

[25]  M. Fisher An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). , 1956, The New England journal of medicine.